Infectious Diseases News

• Blue Faery Recognizes Excellence in Liver Cancer Research
  (April 8, 2025) $25,000 Grant Awarded to Support Innovative Hepatocellular Carcinoma Studies
  
  
• Marquis Who's Who Honors Harvey W. Kaufman, MD, for Excellence in Health Care
  (April 8, 2025) Harvey W. Kaufman, MD, has over 40 years of experience as an expert in pathology
  
  
• Anisur Rahman Siddique Celebrated for a Life Devoted to Protecting the Most Vulnerable
  (April 4, 2025)
  
  
• Marquis Who's Who Honors Manny Singh for Pioneering Innovations in Health Tech and Semiconductor Technology
  (March 27, 2025) Manny Singh is a distinguished expert in miniaturization technology with over 20 years of experience in his field
  
  
• Fatima Donia Mili, MD, PhD, Achieves Prominent Placement in The Wall Street Journal
  (March 27, 2025) Marquis Who's Who is proud to endorse Fatima Donia Mili, MD, PhD, in the Washington/Baltimore Edition of The Wall Street Journal
  
  
• Marquis Who's Who Honors Samuel Li, PhD, for Expertise in Life Sciences, Biotechnology and Pharmaceuticals
  (March 24, 2025) Samuel Li, PhD, is a distinguished scientist with 35 years of experience in the life sciences, biotechnology and biopharmaceutical industries
  
  
• Promoting Drug and Vaccine R&D by Spike Protein Research: Creative Biolabs' Innovative Approach
  (March 21, 2025) With extensive experience in virology, Creative Biolabs, as an industry-leading CRO company, is at the forefront of SARS-CoV-2 vaccine and drug research and development.
  
  
• SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug for the Treatment of Sepsis, Pulmonary Inflammation and Fibrosis at the Respiratory Innovation Summit and ATS Conference 2025
  (March 20, 2025) We will present paradigm-shifting preclinical data on targeting innate inflammation to protect septic mice from death at delayed treatment times as well as to reduce pulmonary inflammation and reverse fibrosis in animal models of lung pathologies.
  
  
• ADAP Advocacy Releases New Policy Paper on 340B Drug Pricing Program
  (March 12, 2025) Is the 340B Drug Pricing Program the Next 'Too Big to Fail'?
  
  
• ADAP Advocacy Releases Supplemental Report on 340B Covered Entities
  (March 4, 2025) The 340B Drug Pricing Program and Its Potential Impacts on Annual Revenues, Executive Compensation, and Charity Care Provision in Eligible Covered Entities
  
  
• ADAP Advocacy Files Amicus Curiae Briefs Supporting 340B Rebate Model
  (February 11, 2025) Two amicus briefs offer distinctly patient-focused perspective on the importance of the rebate model to patients and why that model is so desperately needed
  
  
• ADAP Advocacy Names William Sarraille as Special Counsel for 340B Issues
  (February 6, 2025) Sarraille is a nationally recognized expert in health care, life sciences, drugs, medical devices, and patient access to treatments
  
  
• Frederick Lobati, MD, FACP, MRCP, Honored for Contributions to Health Care
  (February 6, 2025) Frederick Lobati, MD, FACP, MRCP, celebrated for over 35 years of industry experience
  
  
• Marquis Who's Who Honors Daniel L. Shungu, PhD, for Expertise in Leadership and Disease Control
  (February 4, 2025) Daniel L. Shungu, PhD, serves as the founder and chief executive officer of the United Front Against Riverblindness
  
  
• Marquis Who's Who Honors Roberto Mulberry de Araujo, MD, for Expertise in Biotechnology
  (February 1, 2025) Roberto Mulberry de Araujo, MD, is a distinguished researcher of rare diseases at Sanofi Genzyme
  
  
• Love Your Liver: Blue Faery Amplifies Health Awareness During Black History Month
  (January 31, 2025) Empowering Black communities with life-saving knowledge about liver cancer through free virtual workshops and culturally focused education.
  
  
• Marquis Who's Who Honors Tarek Souaid, MD, MPH, for Expertise in Health Care
  (January 30, 2025) Tarek Souaid, MD, MPH, is recognized for his contributions to the medical field in internal medicine at the Cleveland Clinic
  
  
• Dinesh R. Vannan has been Inducted into the Prestigious Marquis Who's Who Biographical Registry
  (January 26, 2025) Dinesh R. Vannan serves as the head of U.S. marketing for the lysosomal storage disease portfolio at Chiesi Global Rare Diseases
  
  
• Kumapley Lartevi, MD Celebrated for Dedication to the Field of Medicine
  (January 23, 2025) Kumapley Lartevi, MD, channels years of expertise into his work with The Convenient Clinic
  
  
• Creative Biolabs: Continues Seeking Methods for Drug Discovery Against SARS-CoV-2
  (January 22, 2025) Creative Biolabs makes further progress in its normalized research amid the ongoing mutation of COVID-19.
  
  
• WHISTLEBLOWER SLAMS CONGRESSIONAL COVID COVER-UP AS "GENOCIDAL"
  (December 30, 2024) 30-Year Lab Virus Vaccine Veteran Presents Sworn Documents in Video Evidencing COVID-19's Bioweaponization from HIV-1/AIDS.
  
  
• Frederick Lobati Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who
  (December 23, 2024) Frederick Lobati has been endorsed by Marquis Who's Who as a leader in the field of medicine
  
  
• Creative Biolabs Launches Comprehensive Monkeypox Product Line
  (December 14, 2024) Creative Biolabs has been paying close attention to the development of the epidemic situation and is committed to supporting the fight against monkeypox with a comprehensive product line.
  
  
• Marquis Who's Who Honors Sarah Abdulaziz Alobaid, PhD, for Expertise in Higher Education and Research and Development
  (December 11, 2024) Sarah Abdulaziz Alobaid, PhD, is an expert in microbiology as a dedicated educator and researcher
  
  
• ADAP Advocacy Publishes Infographic Series on the 340B Program
  (November 25, 2024) Infographics analyze hospital revenues and executive compensation, compared to hospital charity care and patient medical debt
  
  
• Marquis Who's Who Honors Obinna Onyekwena, MD, for Expertise in Medicine and Nonprofit Health Care
  (November 20, 2024) Obinna Onyekwena, MD, is a distinguished expert in global health and global infectious diseases
  
  
• Leading Science Analyst Drafts Congressional Repeal of Vaccine Injury Law Protecting Big Pharma Against Liability
  (November 17, 2024) Robert F. Kennedy, Jr. HHS Secretary Appointment Encourages Bureaucratic Review and Alternative Remedies.
  
  
• Revolutionary Upgraded Diuretic and Anti-inflammatory Pill: Effective Solution for Chronic Prostatitis and Prostate Cancer Prevention
  (October 25, 2024) With advancements in medicine, the newly upgraded Diuretic and Anti-inflammatory Pill is considered an important option for treating chronic prostatitis and preventing prostate cancer.
  
  
• COVID19/SARS2 in Middlesex County, Massachusetts: A Pilot Community Report, vaccines vs. antiviral response
  (September 11, 2024) Considering the major societal disruptions brought on by government mandates responding to the COVID19 pandemic, all communities owe their residents an objective review of the mandates imposed.
  
  
• SARS2/COVID 19 in Middlesex County, Massachusetts: A Pilot Community Report
  (September 6, 2024) A data driven report on the spread of COVID 19 in Middlesex County, Massachusetts
  
  

Press Release Distribution News Supplied By 24-7PressRelease.com